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1. Introduction 
The rapidly increasing diagnostic and thera- 
peutic possibilities, the high-quality demands by 
patients and public and the pressure for cost 
containment all contribute to the importance of 
trying to develop more explicit approaches to 
clinical reasoning and decision making. The rise 
of clinical decision theory, which is concerned 
with the quantitative study of decision problems 
in individual patient care, can partly be seen as a 
response to this challenge. 
A science of clinical decision making is possi- 
ble because reasoning processes in diagnostics 
(what is wrong?), prognosis (what will happen?) 
and therapy choice (what can be done about it?) 
obey laws which are independent of the particu- 
lar clinical domain of application. Clinical deci- 
sion theory is truly a multi-disciplinary science. It 
uses methods and results from many fields includ- 
ing mathematical decision theory, probability the- 
ory, epidemiology, statistics, informatics, and cog- 
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nitive psychology. The core method is decision 
analysis, i.e. the comparative assessment of clini- 
cal strategies. Some basic concepts of decision 
analysis will be discussed and illustrated in this 
paper. An annotated bibliography is included for 
further study. 
2. Diagnosis 
Diagnosis is not an aim in itself in clinical 
medicine; it is important because of its implica- 
tions for prognosis and treatment. Contrary to 
the idea of many lay people, absolute diagnostic 
certainty can only seldom be reached in clinical 
practice. Moreover, certainty can sometimes only 
be obtained by performing risky (invasive) diag- 
nostic tests. The notions of diagnostic probability 
and its revision because of further diagnostic 
evidence are central to diagnostic reasoning. Al- 
though diagnostics i  an important subject in clin- 
ical decision sciences, it will not be discussed in 
the present paper. In our discussion of therapy 
choice we will simply assume that we are already 
at the end of the diagnostic process for a particu- 
lar patient, and that the treatment decision re- 
mains (see, however, Section 5). 
We will illustrate the concepts with the case of 
a patient with possible deep venous thrombosis 
(DVT). We assume that we are at the end of the 
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Table 1 
Cross-tabulation f treatment choice and underlying disease, 
indicating the two types of right and wrong decisions that can 
be made. P(DVT) and P(noDVT) are the probabilities of 
DVT resp. no DVT at the moment that the treatment deci- 
sion has to be made 
Choice for Choice for 
treatment No treatment 
Patient has Rightly treated Wrongly not treated 
DVT P(DVT) P(DVT) 
Patient has Wrongly treated Rightly not treated 
no DVT P(noDVT) P(noDVT) 
diagnostic process and that uncertainty remains 
as to whether a patient has DVT or not. We 
indicate this by the following symbolism: 
P(DVT): Probability that the patient has DVT, 
P(noDVT): Probability that the patient has no 
DVT. 
Whether the patient has the disease or not, 
these probabilities have to add up to 100%. 
The clinician has to choose for anti-coagula- 
tion treatment or not, but because of the diagnos- 
tic uncertainty, he will not know if he makes the 
right choice (see the schedule in Table 1). 
When the clinician chooses treatment, he will 
be choosing rightly when the disease is present, 
i.e. with probability P(DVT), but with a comple- 
mentary probability P(noDVT) he will treat the 
patient wrongly. When the option "no treatment" 
is chosen, the two probabilities are reversed: with 
P(noDVT) the patient is rightly not treated, and 
with P(DVT) the patient is wrongly not treated. 
The general strategy that a clinician will follow 
is to choose for treatment when the probability of 
DVT, P(DVT), is high, and to choose not to treat 
when the probability of no DVT, P(noDVT), is 
high. One of the questions which can be ad- 
dressed by decision analysis is: What is the treat- 
ment threshold ualue for the diagnostic probability 
P(DVT), above which the patient should be 
treated and below which he should not be treated. 
The value of this threshold will depend on the 
relative seriousness of the two types of wrong 
decisions. In other words: What adverse out- 
comes may result with what chances for the two 
types of wrong decisions? This leads us to a 
discussion of outcomes, before we go to calculate 
the treatment threshold. 
3. Outcome 
Outcome plays a central role in clinical 
medicine because we aim to choose the treatment 
which makes the expected outcome for the pa- 
tient as favourable as possible. Depending on the 
clinical situation at hand, outcome may include 
many aspects, such as inconvenience and risks of 
diagnostic tests, risks, side-effects and duration of 
the treatment process, and longevity and health 
status during the patient's further life. 
It is not known beforehand what long-term 
outcome the patient will experience and what 
risks and side-effects will be realized. Thus, at the 
time of treatment choice the outcome is uncer- 
tain and bears a probabilistic character. Most 
aspects of outcome can be classified under the 
two broad categories of length of life and quality 
of life. 
For our patient with possible DVT, four out- 
comes have to be assessed: those of non-DVT 
patients and DVT patients, under the therapeutic 
options yes or no anti-coagulation therapy. We 
will limit ourselves to what in this situation is the 
most important aspect of outcome, namely short- 
term mortality. 
Based on evidence from the literature we have 
made the following short-term mortality esti- 
mates: 
DVT patient without therapy: 
DVT patient with therapy: 
non-DVT patient with therapy: 
non-DVT patient without therapy: 
10% chance 
of a fatal em- 
bolism; 
2% chance of 
a fatal bleed- 
ing or a fatal 
embolism; 
1% chance of 
fatal b leed- 
ing; 
0% mortality 
chance. 
These outcomes can be specified in the same 
cross-tabulation as in Table 1. 
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Because we have limited ourselves to the 
short-term mortality aspect of outcome, there is 
no problem of incomparable types of outcome. 
When mortality is spread out over a long time 
period, the theory of survival curves should be 
used in comparing the mortality experience be- 
tween treatment options. 
When health status is also affected by 
(non)treatment, he impact on quality of life 
should be assessed. There are several techniques 
for doing this, although they are not yet applied 
in routine practice. 
Survival in the short and the long run has to be 
combined with quality-of-life considerations. How 
these different aspects can be weighted in order 
to make an overall comparison between thera- 
peutic options is beyond the scope of this paper. 
The most widely used concept in this respect is 
that of "quality-adjusted life year" (QALY) [see 
Refs. 1, 3]. 
4. The treatment hreshold 
Should we treat our patient with possible DVT 
or not? (Remember that we assumed that we are 
at the end of the diagnostic process.) Apparently, 
treatment is of benefit o the patient when he has 
DVT, and is of risk to the patient when he has no 
DVT. The magnitude of these benefits and risks 
can be calculated from Table 2: 
The benefit of treatment to the DVT patient 
amounts to a reduction in mortality risk of 8%, 
because the mortality risk with treatment is 2% 
instead of the 10% risk without treatment. 
The risk of anti-coagulation treatment to the 
noDVT patient is 1%. This is the fatal bleeding 
risk incurred by the treatment. 
Table 2 
Consequences in terms of short-term ortality for the four 
combinations of treatment choice and underlying disease. See 
also Table 1 
Choice for Choice foi" 
treatment No treatment 
Patient has 2% mortality 10% mortality 
DVT P(DVT) P(DVT) 
Patient has 1% mortality 0% mortality 
no DVT P(noDVT) P(noDVT) 
Mortality Mortality 8% 
risk benefit 
0ojo ,4  ,0 o' . 'o  ,'ojo 7'o o 8'°,° 9;°,° ,00o,  
~.'°'° p(DVT) 
Probability of Deep Venous Thrombosis 
Fig. 1. Graphical representation f the calculation of the 
treatment threshold in the case of a patient with possible 
DVT. The benefit of treating aDVT patient amounts to a 8% 
mortality reduction, and the risk of treating a non-DVT 
patient is 1%. Benefit and risk are exactly in balance for a 
DVT probability of 11.1% (this is the value where the bene- 
fit/risk ratio of 8:1 in favour of treatment is balanced by a 
ratio in diagnostic probabilities of 1:8 against DVT). For 
diagnostic values over 11.1%, anti-coagulation treatment is
preferred, for values under 11.1% it is not. 
The balance of benefits and risks in an actual 
patient depends on the diagnostic probability 
P(DVT) that the patient has DVT. When we are 
absolutely certain that the patient indeed has 
DVT (i.e., a diagnostic probability of 100%), 
treatment is only of benefit and carries no risk. In 
the other extreme situation, a patient with 0% 
chance of DVT, we run only the full 1% risk and 
have no benefit. In all intermediate cases, bene- 
fits and risks have to be weighted with the proba- 
bility of DVT or no DVT (see Fig. 1). 
The conclusion from Fig. 1 is that anti-coagu- 
lation treatment should be chosen when the 
probability of DVT exceeds 11%. But remember 
that this threshold value critically depends on the 
8:1 benefit/r isk ratio assumption. Sensitivity 
analysis is the name of the method that is used to 
assess this dependency. It can be used to explore 
how sensitive the conclusions are to the assump- 
tions about benefit and risk. For example, when 
you don't know the exact benefit/r isk ratio, but 
you are pretty sure that it will lie somewhere 
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between 15:1 and 5:1, you are pretty sure by 
implication that the treatment threshold will lie 
somewhere between 6% and 16% (try to check 
these values). This gives you a more realistic first 
clinical guideline: In the case of low (< 6%) or 
"high" (> 16%) values for the probability of deep 
venous thrombosis, the results of the analysis 
point rather compellingly to no treatment or 
treatment; but for the range of diagnostic proba- 
bilities between 6% and 16%, the preferred 
course of action is not so clear-cut, and other 
considerations than short-term mortality which 
might influence the treatment choice will become 
more important. 
Most treatment decisions are more complex 
than the one we analyzed here (more diagnostic 
and therapeutic alternatives, more aspects of out- 
come, a long-term time-perspective, etc.), but the 
process of balancing the possible benefits and 
risks remains essentially the same. 
5. Treatment, or further diagnostics? The test- 
treatment thresholds 
How much uncertainty at the end of the diag- 
nostic process is realistic in patients with possible 
DVT? Ultrasonography can indeed lead to incon- 
clusive results, which leave a wide range of possi- 
ble diagnostic probabilities. But venography, the 
golden standard diagnostic method, should give 
(near)certainty about the presence or absence of 
DVT. Should we therefore always perform venog- 
raphy when diagnostic uncertainty remains after 
ultrasound? The answer would be affirmative-- 
apart from cost considerations--in case venogra- 
phy would have been risk-free. But this is not the 
case: it carries a non-negligible risk of fatal com- 
plications. Decision analysis can again be used to 
address the question under what conditions the 
benefit of venography--namely, a safer treat- 
ment choice afterwards--exceeds the risk of 
venography. If not, it would be better to make a 
direct treatment choice. 
Let us assume a fatal risk of venography of 
0.2%. Graphically, we have to add a third line to 
the two lines in Fig. 1, representing the choice of 
venography. This has been done in Fig. 2. The 
Mortality Mortality l risk benefit 
1% ~i&~-, 8% 
0.2% 0.2% 
b I I I r i I I i 
0% I 10% 20*/* 30% 40% 50% 60°1. 70% I 90% 100% 
2'~°/° p(DVT) ~O°/o 
Probability ofDeep Venous Thrombosis 
Fig. 2. Graphical representation f the calculation of the two 
test-treatment thresholds in the case of a patient with possible 
DVT. Venography carries a 0.2% mortality risk, and is as- 
sumed to be a gold standard iagnosis. The no-treatment-test 
threshold lies at a 2.5% probability of DVT, and the test- 
treatment threshold at 80% probability. 
diagnostic probabilities on the horizontal axis 
should now be interpreted as representing the 
diagnostic judgement after ultrasound but before 
venography. After venography, we will always end 
up in the "risk-free" situation of 100% diagnostic 
certainty, so no other risk except he venography 
risk is incurred. The venography-risk line will 
therefore be a horizontal line of a constant 0.2% 
risk, irrespective of the diagnostic probabilities 
before venography. 
We will now end up with two thresholds: one 
at 2.5% probability of DVT and the other at 80% 
probability. The interpretation is as follows. When 
DVT is at least 80% certain, or the absence of 
DVT is at least 97.5% certain, a direct (no-)treat- 
ment choice should be made. If the diagnostic 
probability of DVT lies between 2.5% and 80%, 
the risk of venography is acceptable in view of the 
diagnostic information it produces. Sensitivity 
analysis can be used to assess the dependency of 
the threshold values on the three risk assump- 
tions. 
Graphical illustration of decision problems by 
figures like those discussed so far is only possible 
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PATIENT WITH 
POSSIBLE DVT 
TREAT 
(Anticoagulantia) 
mortality: 
DVT P~I DVT) 
o OVT 4- l~q. 
p(no DVT) 
FATAL COMPLICATION 
} 0.2% positive ~ITREAT 
[ J p(OVT) 
]VENOG RAPHY ( ~ . ~  
9&~ ] negative [ ]  DO NOT TREAT i~  ~ 
p(no DVT) 
DO NOT TREAT 
DVT 
P~i DVT) 
0 DVT 
p(no DVT) 
Fig. 3. Decision tree for a patient with possible DVT, with the 
three options of treatment, no treatment and further diagnos- 
tics. Squares indicate choices, circles indicate uncertain out- 
comes or test results, and rectangles indicate outcomes. The 
quantification of the tree will be completed by specifying 
values for the probability of DVT, P(DVT), and the probabil- 
ity of no DVT, P(noDVT), It can subsequently becalculated 
what option gives the lowest mortality risk. (See Fig. 2 for an 
alternative representation f this choice situation.) For the 
relevant calculations for this tree, including the derivation of 
the treatment threshold and the two test-treatment thresh- 
olds, see Appendix 1. 
in rather simple situations. In the more general 
case, a decision tree can be used to illustrate the 
clinical problem, and to guide the subsequent 
calculations (see Fig. 3). 
6. Discussion 
This completes our introduction to some basic 
concepts of clinical decision theory. We have 
chosen to embark directly on the study of a 
clinical problem, in order to demonstrate how 
decision theory can help with comparing clinical 
management options. 
Clinical decision theory is not an attempt o 
develop a theory of dehumanized automated e- 
cision making. On the contrary, the value of 
decision theory will depend on how well it can 
provide decision support in the context of the 
traditional patient-physician e counter. In a de- 
cision analysis it is impossible to take all (subtle) 
considerations into account which might influ- 
ence the subsequent choice of action. Clinician 
and patient, in their often difficult decision mak- 
ing process, have to judge the relevance and 
exhaustiveness of the results of the decision anal- 
ysis for their particular problem. They have to 
adapt the results, sometimes radically, when im- 
portant medical or other considerations have not 
been taken into account in the decision analysis. 
The experienced clinician-decision analyst will 
only selectively use decision theory as in our 
analysis of the DVT example. But he will contin- 
uously apply the principles of decision analysis 
informally, and will develop an increasingly sharp 
intuitive judgement on the conclusion he would 
have drawn from a more complete analysis. 
See the references for a further discussion of 
use and limitations of decision theory, and for 
further development of theory and applications. 
Appendix I: Calculation for the decision tree of 
Fig. 3, or equivalent, for Fig. 2 
Probability of mortality (M) for the three options of 
Treatment (T), Venography (V) and no Treatment 
(noT) 
P(MI  T) = 2% X P (DVT)  + 1% ×P(noDVT) 
P (MIV)  = 0.2% + 99.8% X 2% XP(DVT)  
P(MlnoT)  = 10% XP(DVT)  
The threshold values for the probability of 
DVT are derived by equating the relevant mortal- 
ity chances, and solving for P(DVT). 
Treatment - no treatment threshold 
P( M I T) = P( M InoT) 
This gives: 
8% P(DVT)  = 1% P(noDVT) 
Thus, 
P(DVT)  = 1/9 = 11.1% 
No treatment - venography threshold 
P( M I noT) = P( M [ V) 
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This  gives: 
8% P( DVT)  = 0.2% 
Thus, 
P(  DVT)  = 2.5% 
Venography - treatment threshold: 
P (MIV)  =P(MIT)  
This  gives: 
0 .2% = 1% P(noDVT)  
Thus,  
P( noDVT) = 20%,  
and 
P(DVT)  = 80% 
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